Drugs / HPV 16 L1 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00365378 | Sep 1999 → Mar 2004 | human papilloma virus infection | Merck Sharp & Dohme LLC | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV 16 L1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00365378 ↗ |
| Modality | Vaccine | “HPV 16 Virus-Like Particle (VLP) Vaccine” NCT00365378 ↗ |
| Route | Intramuscular | “A 0.5 intramuscular injection given at Day 1, Month 2, and Month 6” NCT00365378 ↗ |